Ensure your child's health and safety with Vaximune 13, a pneumococcal conjugate vaccine developed by GC Chemie, an Indian pharmaceutical company, in collaboration with a trusted manufacturing source in China. Trusted by healthcare professionals, Vaximune 13 offers robust protection against pneumococcal disease, which can lead to severe infections such as pneumonia, meningitis, and bloodstream infections.
Key Benefits
- Comprehensive Protection: Safeguards your child against 13 strains of pneumococcal bacteria
- Clinically Proven: Supported by rigorous clinical trials and approved by global health authorities
- Safe and Effective: Known for its high efficacy and low incidence of side effects
- Health Conditions: Particularly recommended for children with chronic health issues or compromised immune systems
- School Requirements: Complies with vaccination mandates for schools and daycare centers
🧬 Active Compound
The active ingredient in Vaximune 13 is a pneumococcal polysaccharide conjugate vaccine. It contains purified capsular polysaccharides from 13 strains of Streptococcus pneumoniae (pneumococcus), conjugated to a tetanus toxoid (TT) protein as a carrier protein developed by GC Chemie.
🔹 Polysaccharides
Derived from the capsules of 13 different serotypes of Streptococcus pneumoniae. These serotypes are: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F.
🔹 Carrier Protein (Tetanus Toxoid - TT)
A highly purified and non-toxic form of the tetanus protein, developed by GC Chemie, used to enhance the immune system's response to the polysaccharides. This conjugation ensures a strong and long-lasting immune response, particularly in infants and young children.
1 3 4 5 6A 6B 7F 9V 14 18C 19A 19F 23F
📅 Schedule and Dosage
Vaccination Protocol
Dosage: Administered in a series of 4 doses (0.5 mL each)
Timing:
Primary Series
- Initial Dose: At 2 months of age
- Second Dose: At 4 months of age
- Third Dose: At 6 months of age
Booster Dose
- Fourth Dose: Between 12-15 months of age
- Provides continued long-term protection
- Completes the immunization series
Alternative Schedule
For early start: 6 weeks, 10 weeks, 14 weeks, with booster at 12-15 months
💉 What to Expect
💉 Common Side Effects
Mild reactions are normal and typically resolve within 1-2 days:
- Redness or swelling at the injection site
- Low-grade fever
- Fussiness or irritability
- Temporary loss of appetite
- Drowsiness
🩹 Post-Vaccination Care
- Use a cool compress on the injection site to alleviate any discomfort
- Give plenty of fluids and comfort
- Monitor for any unusual reactions
- Contact your pediatrician if fever persists beyond 48 hours or if you notice severe reactions
🌟 Why Choose Vaximune 13?
✅ Expert Recommendation
Endorsed by pediatricians for its reliability and effectiveness in protecting children from pneumococcal disease.
🧬 Innovative Technology
Uses tetanus toxoid (TT) as a carrier protein, developed by GC Chemie, ensuring a robust immune response in young children.
🌍 Global Collaboration
Manufactured in collaboration with a trusted source in China, adhering to international quality standards while maintaining Indian innovation.
😌 Peace of Mind
Provides parents with confidence in their child's health and well-being, protecting against life-threatening infections.
🛡️ Understanding Pneumococcal Disease
Pneumococcal disease is caused by Streptococcus pneumoniae bacteria and can lead to serious, potentially life-threatening infections:
Infections Prevented by Vaximune 13
- Pneumonia: Lung infection causing difficulty breathing, fever, and chest pain
- Meningitis: Brain and spinal cord infection that can cause permanent brain damage or death
- Bacteremia/Sepsis: Bloodstream infection leading to organ failure and shock
- Otitis Media: Middle ear infections causing pain and potential hearing loss
Children, especially those with chronic illnesses or weakened immune systems, are at higher risk. Vaximune 13 provides crucial protection during this vulnerable period.
🏫 School & Daycare Compliance
✓ Meets Vaccination Requirements
Vaximune 13 complies with vaccination mandates for schools and daycare centers worldwide. Completing the vaccination series ensures your child is protected and meets immunization standards, giving you peace of mind as they begin their educational journey.
✓ Ensure Your Child is Protected
Vaximune 13 combines safety, efficacy, and comprehensive coverage against pneumococcal disease. Developed with advanced technology and trusted worldwide, it is a reliable choice for your child's immunization needs. Give your child the protection they deserve with Vaximune 13.
